Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2013
07/25/2013US20130188270 Oxime ester
07/25/2013CA2863517A1 Substituted pyrimidine compounds and their use as syk inhibitors
07/25/2013CA2861442A1 Piperazinyl pyrimidine derivatives, preparation method and use thereof
07/24/2013EP2617723A2 Novel compound acting as a cannabinoid receptor-1 inhibitor
07/24/2013EP2617717A1 P2x4 receptor antagonist
07/24/2013EP2617712A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same
07/24/2013EP2616463A2 Preparation of crystalline bazedoxifene and its salts
07/24/2013EP2616462A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/24/2013EP2616461A2 Potent and selective inhibitors of hepatitis c virus
07/24/2013EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
07/24/2013EP2616447A1 Pyrazine derivatives as enac blockers
07/24/2013EP2616443A1 Phtalazine derivatives as jak1 inhibitors
07/24/2013EP2616441A2 Pyridine compounds and the uses thereof
07/24/2013EP2616437A1 Pesticidal arylpyrrolidines
07/24/2013EP2616070A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
07/24/2013CN1980899B Quinazolinone derivatives as parp inhibitors
07/24/2013CN103221406A Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/24/2013CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors
07/24/2013CN103221403A Heterocyclic compounds and their uses
07/24/2013CN103221402A Triazole derivatives and their use for neurological disorders
07/24/2013CN103221398A Tetrazine-trans-yclooctene ligation for the rapid construction of radionuclide labeled probes
07/24/2013CN103221397A New compositions and methods for controlling nematode pests
07/24/2013CN103214468A Hairpin polyamide modified by chiral (S)-beta-hydroxyl-gamma-amino acid and application for same
07/24/2013CN103214467A 5-[[4-[(2, 3-dimethyl-2H-indazole-6-yl) methylamino]-2-pyrimidyl] amino]-2-methyl-benzsulfamide derivative and preparation method and applications thereof
07/24/2013CN103214466A Methyl arylpyrazole fluorouracil compounds, and preparation method and application thereof
07/24/2013CN103214465A Halogen benzyl pyrazole compounds comprising fluorouracil, and preparation method and application thereof
07/24/2013CN103214376A Substituted 4-aminocyclohexane derivatives
07/24/2013CN102336745B 5-azobenzene and synthesis method thereof
07/24/2013CN102307948B Azo pigment, method for producing azo pigment, dispersion containing azo pigment, and coloring composition
07/24/2013CN102219751B Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof
07/24/2013CN102093341B Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof
07/24/2013CN101885722B Heterocycle alkyne and benzene compound, medicinal composition and application thereof
07/24/2013CN101570504B Novel compounds for electronic material and organic electronic device using the same
07/24/2013CN101362773B Heterocyclic boronic acid compounds
07/24/2013CN101258131B 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
07/23/2013US8492560 Quinazoline derivatives as angiogenesis inhibitors
07/23/2013US8492545 Aminothiazole compounds as kinase inhibitors and methods of using the same
07/23/2013US8492544 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compound
07/23/2013US8492540 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
07/23/2013US8492428 Small-molecule botulinum toxin inhibitors
07/23/2013US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
07/23/2013US8492397 Aminopyridine derivatives having Aurora A selective inhibitory action
07/23/2013US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta
07/23/2013US8492387 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
07/23/2013US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
07/23/2013US8492111 Arylalkylamine compound and process for preparing the same
07/23/2013CA2735828C Substituted-(naphthalen-1-yl)-1h-imidazoles and their use for modulating uric acid levels
07/23/2013CA2599348C Indole compound and use thereof
07/18/2013WO2013106728A1 Agents that prevent or repair skin damage
07/18/2013WO2013106702A1 Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
07/18/2013WO2013106689A1 Hcv ns3 protease inhibitors
07/18/2013WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists
07/18/2013WO2013105608A1 P2x4 receptor antagonist
07/18/2013WO2013104705A1 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
07/18/2013WO2013104573A1 Pyridazine amide compounds and their use as syk inhibitors
07/18/2013WO2013048949A3 Selective nr2b antagonists
07/18/2013US20130184460 Glycine transporter inhibiting substances
07/18/2013US20130184459 P2x4 receptor antagonist
07/18/2013US20130184301 Methods of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds
07/18/2013US20130184300 Methods of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds
07/18/2013US20130184297 Quinazoline derivatives substituted by aniline, preparation method and use thereof
07/18/2013US20130184277 Adamantyl diamide derivatives and uses of same
07/18/2013US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds
07/18/2013US20130184261 Pyridazinone derivatives
07/18/2013US20130184260 Pyridazinone derivatives
07/18/2013US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
07/18/2013US20130184251 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
07/18/2013US20130184248 Novel compounds
07/18/2013US20130184238 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
07/18/2013US20130183269 Hepatitis C Virus Inhibitors
07/17/2013EP2615087A2 Phenylalanine derivatives
07/17/2013EP2614053A1 Method for producing pyridazinone compounds and intermediate thereof
07/17/2013EP2614052A1 Novel piperazine analogs as broad-spectrum influenza antivirals
07/17/2013EP2614051A2 P53-mdm2 antagonists
07/17/2013CN1997340B Disulfide dyes, composition comprising them and method of dyeing
07/17/2013CN103209978A Novel phase transfer catalysts
07/17/2013CN103209977A Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
07/17/2013CN103209976A 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
07/17/2013CN103204847A Preparation method of side chain type imidazolyl benzdine
07/17/2013CN103204846A Carbazole derivative, organic electroluminescent device thereof, and manufacturing method of device
07/17/2013CN103204845A Imidazolyl ionic liquid, and synthesizing method and application thereof
07/17/2013CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof
07/17/2013CN103204813A Condensed imidazole derivatives as TRPV3 antagonist
07/17/2013CN102186477B Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
07/17/2013CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
07/17/2013CN102093340B Preparation method and application of 2-methylindazole derivatives
07/17/2013CN102083820B Pyrrolidin-3-ylmethyl-amine as orexin antagonists
07/17/2013CN101903362B Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists
07/17/2013CN101687857B Pyridazinone derivates
07/17/2013CN101641339B Compounds for the prevention and treatment of cardiovascular diseases
07/17/2013CN101511821B Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
07/17/2013CN101479008B Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol
07/16/2013US8487116 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
07/16/2013US8487096 Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors
07/16/2013US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/16/2013US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders
07/16/2013US8486955 Anti-cancer cyclopenta [g] quinazoline compounds
07/16/2013US8486933 Pyrimidine inhibitors of kinase activity
07/16/2013CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates
07/16/2013CA2699674C 5-ht7 receptor antagonists
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 626